1. 1002. A Daily Single Tablet Regimen (STR) of Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) in Virologically-Suppressed Adults Living with HIV and End Stage Renal Disease on Chronic Hemodialysis. (31st December 2020) Authors: Eron, Joseph J; Wilkin, Aimee; Ramgopal, Moti; Osiyemi, Olayemi; McKellar, Mehri; McKellar, Mehri; Slim, Jihad; Asmuth, David; DeJesus, Edwin; German, Polina; Blair, Christiana; Carter, Christoph C; Brainard, Diana M; Collins, Sean E; Martin, Hal Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S529 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 985. Impact of Age and Medical Comorbidities on Renal Outcomes in the DISCOVER Trial. (31st December 2020) Authors: Daar, Eric; Brunetta, Jason; Cua, Eric; Flamm, Jason; Asmuth, David; Carter, Christoph C; Shao, Yongwu; Wong, Pamela; Ebrahimi, Ramin; Das, Moupali; Brainard, Diana M; Clarke, Amanda Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S521 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Continued Elevation of Interleukin-18 and Interferon-γ After Initiation of Antiretroviral Therapy and Clinical Failure in a Diverse Multicountry Human Immunodeficiency Virus Cohort. (27th July 2016) Authors: Balagopal, Ashwin; Gupte, Nikhil; Shivakoti, Rupak; Cox, Andrea L.; Yang, Wei-Teng; Berendes, Sima; Mwelase, Noluthando; Kanyama, Cecilia; Pillay, Sandy; Samaneka, Wadzanai; Santos, Breno; Poongulali, Selvamuthu; Tripathy, Srikanth; Riviere, Cynthia; Lama, Javier R.; Cardoso, Sandra W.; Sugandhav... Journal: Open forum infectious diseases Issue: Volume 3:Number 3(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 7 (July 2021) Authors: Ogbuagu, Onyema; Ruane, Peter J; Podzamczer, Daniel; Salazar, Laura C; Henry, Keith; Asmuth, David M; Wohl, David; Gilson, Richard; Shao, Yongwu; Ebrahimi, Ramin; Cox, Stephanie; Kintu, Alexander; Carter, Christoph; Das, Moupali; Baeten, Jared M; Brainard, Diana M; Whitlock, Gary; Brunetta, Jason... Journal: Lancet Issue: Volume 8:Issue 7(2021) Page Start: e397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Sex-Related Differences in Inflammatory and Immune Activation Markers Before and After Combined Antiretroviral Therapy Initiation. (1st October 2016) Authors: Mathad, Jyoti S.; Gupte, Nikhil; Balagopal, Ashwin; Asmuth, David; Hakim, James; Santos, Breno; Riviere, Cynthia; Hosseinipour, Mina; Sugandhavesa, Patcharaphan; Infante, Rosa; Pillay, Sandy; Cardoso, Sandra W.; Mwelase, Noluthando; Pawar, Jyoti; Berendes, Sima; Kumarasamy, Nagalingeswaran; Andra... Journal: Journal of acquired immune deficiency syndromes Issue: Volume 73:Number 2(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Women are from venus: implications for diversified sex-based preexposure prophylaxis approaches. (1st August 2021) Authors: Marchetti, Giulia; Asmuth, David Journal: AIDS Issue: Volume 35:Number 10(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗